Human RNF149/DNAPTP2 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_173647)
Cat. No.: pGMPC001610
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human RNF149/DNAPTP2 Non-Viral expression plasmid (overexpression vector) for mouse RNF149 overexpression in unique cell transient transfection and stable cell line development.
Go to
RNF149/DNAPTP2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMPC001610 |
Gene Name | RNF149 |
Accession Number | NM_173647 |
Gene ID | 284996 |
Species | Human |
Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
Insert Length | 1203 bp |
Gene Alias | DNAPTP2 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | MYC (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCGTGGCGGCGGCGCGAAGCCAGCGTCGGGGCTCGCGGCGTGTTGGCTCTGGCGTTGCTCGCCCTGGCCCTGTGCGTGCCCGGGGCCCGGGGCCGGGCTCTCGAGTGGTTCTCGGCCGTGGTAAACATCGAGTACGTGGACCCGCAGACCAACCTGACGGTGTGGAGCGTCTCGGAGAGTGGCCGCTTCGGCGACAGCTCGCCCAAGGAGGGCGCGCATGGCCTGGTGGGCGTCCCGTGGGCGCCCGGCGGAGACCTCGAGGGCTGCGCGCCCGACACGCGCTTCTTCGTGCCCGAGCCCGGCGGCCGAGGGGCCGCGCCCTGGGTCGCCCTGGTGGCTCGTGGGGGCTGCACCTTCAAGGACAAGGTGCTGGTGGCGGCGCGGAGGAACGCCTCGGCCGTCGTCCTCTACAATGAGGAGCGCTACGGGAACATCACCTTGCCCATGTCTCACGCGGGAACAGGAAATATAGTGGTCATTATGATTAGCTATCCAAAAGGAAGAGAAATTTTGGAGCTGGTGCAAAAAGGAATTCCAGTAACGATGACCATAGGGGTTGGCACCCGGCATGTACAGGAGTTCATCAGCGGTCAGTCTGTGGTGTTTGTGGCCATTGCCTTCATCACCATGATGATTATCTCGTTAGCCTGGCTAATATTTTACTATATACAGCGTTTCCTATATACTGGCTCTCAGATTGGAAGTCAGAGCCATAGAAAAGAAACTAAGAAAGTTATTGGCCAGCTTCTACTTCATACTGTAAAGCATGGAGAAAAGGGAATTGATGTTGATGCTGAAAATTGTGCAGTGTGTATTGAAAATTTCAAAGTAAAGGATATTATTAGAATTCTGCCATGCAAGCATATTTTTCATAGAATATGCATTGACCCATGGCTTTTGGATCACCGAACATGTCCAATGTGTAAACTTGATGTCATCAAAGCCCTAGGATATTGGGGAGAGCCTGGGGATGTACAGGAGATGCCTGCTCCAGAATCTCCTCCTGGAAGGGATCCAGCTGCAAATTTGAGTCTAGCTTTACCAGATGATGACGGAAGTGATGACAGCAGTCCACCATCAGCCTCCCCTGCTGAATCTGAGCCACAGTGTGATCCCAGCTTTAAAGGAGATGCAGGAGAAAATACGGCATTGCTAGAAGCCGGCAGGAGTGACTCTCGGCATGGAGGACCCATCTCCTAG |
ORF Protein Sequence | MAWRRREASVGARGVLALALLALALCVPGARGRALEWFSAVVNIEYVDPQTNLTVWSVSESGRFGDSSPKEGAHGLVGVPWAPGGDLEGCAPDTRFFVPEPGGRGAAPWVALVARGGCTFKDKVLVAARRNASAVVLYNEERYGNITLPMSHAGTGNIVVIMISYPKGREILELVQKGIPVTMTIGVGTRHVQEFISGQSVVFVAIAFITMMIISLAWLIFYYIQRFLYTGSQIGSQSHRKETKKVIGQLLLHTVKHGEKGIDVDAENCAVCIENFKVKDIIRILPCKHIFHRICIDPWLLDHRTCPMCKLDVIKALGYWGEPGDVQEMPAPESPPGRDPAANLSLALPDDDGSDDSSPPSASPAESEPQCDPSFKGDAGENTALLEAGRSDSRHGGPIS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-IP1512-Ab | Anti-RNF149 monoclonal antibody |
Target Antigen | GM-Tg-g-IP1512-Ag | RNF149 protein |
ORF Viral Vector | pGMLP001220 | Human RNF149 Lentivirus plasmid |
ORF Viral Vector | pGMPC001610 | Human RNF149 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLP001220 | Human RNF149 Lentivirus particle |
Target information
Target ID | GM-IP1512 |
Target Name | RNF149 |
Gene ID | 284996, 67702, 710926, 363222, 101085620, 481333, 506267, 100059079 |
Gene Symbol and Synonyms | 1600023E10Rik,DNAPTP2,Gm15832,Greul4,RNF149 |
Uniprot Accession | Q8NC42 |
Uniprot Entry Name | RN149_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000163162 |
Target Classification | Not Available |
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent protein catabolic process. Predicted to act upstream of or within cellular response to xenobiotic stimulus; negative regulation of MAPK cascade; and regulation of protein stability. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.